Angina pectoris, often shortened to angina, is chest pain or discomfort caused by reduced blood flow to the heart and most ...

A recent study concluded that coronary collateralization is associated with ischemic burden and may reduce the intensity of ...

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...

Sept. 2, 2003 (Vienna) -- Ivabradine, an investigational agent that is the first of a new class of drugs called I f inhibitors, is as effective and safe as atenolol for the treatment of stable angina, ...

A new study conducted by researchers at the Imperial College London suggests that the placebo effect experienced by patients who receive coronary artery stents might be larger than expected, even ...

Please provide your email address to receive an email when new articles are posted on . Abnormal FFR-CT findings were significantly prognostic of poor long-term outcomes in patients with stable angina ...

Researchers at the University of Illinois Chicago have received a $3.12 million National Institutes of Health grant to study whether acupuncture can alleviate chest pain caused by stable angina.

Complete revascularization with PCI results in better health status for patients with multivessel, stable CAD than either incomplete revascularization or a conservative strategy of guideline-directed ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...